Tirzepatide

75,00 €

Bundle & Save

10mg

Free tracked shipping in Europe over €200

Shipping from Finland

Orders are dispatched with tracked delivery across Europe. Delivery timing is confirmed before an order is placed.

For controlled laboratory research only. Not suitable, approved or designed for human consumption, medical treatment, veterinary applications or diagnostic procedures.

Peptide reconstitution calculator

Calculate concentration and syringe units using your approved laboratory protocol.

Research Information

Dual GIP and GLP-1 Receptor Agonist Research Compound

Tirzepatide is a modified peptide studied as a dual GIP and GLP-1 receptor agonist. FDA labeling describes tirzepatide as containing a C20 fatty diacid moiety that enables albumin binding and contributes to extended pharmacokinetic activity.

Overview
Research involving tirzepatide focuses on dual incretin receptor activation, glucose-dependent insulin secretion, glucagon regulation, gastric-emptying pathways, appetite-related signaling, metabolic response, and body-composition endpoints.

Certificate of analysis (PDF)

Full compound research reference Study context, experimental considerations, protocol references, and limitations

Compound reference

Tirzepatide research information

A structured laboratory reference based on the product record and published research context. This is not medical advice or a human-use protocol.

Also known as Tirzepatide

Reported half-life Compound-specific; consult the study literature and analytical documentation

Study schedule Defined by the approved laboratory protocol

Protocol basis Use only an approved, compound-specific laboratory protocol

Mechanism and research overview

Use the research overview from the catalog together with peer-reviewed literature and compound-specific analytical documentation.

Reported research areas

Research interest includes metabolic, incretin, glucose-regulation, and energy-expenditure research.

Experimental considerations

Validate identity, purity, concentration, and handling requirements before study use.
Record all preparation, storage, and study parameters in the laboratory protocol.
This product is not intended for human or veterinary use.

Research protocol reference

Vial strength: Use the selected product variant shown above
Target amount: Enter only the amount specified by your approved protocol
Preparation: Use validated aseptic laboratory procedures
Calculation: Open the peptide calculator

No human dose, treatment schedule, injection route, or prescribing advice is provided.

Research status

Sold as a research compound; regulatory status varies by jurisdiction and study context.

Research-use limitations

Not for human consumption, treatment, diagnosis, or veterinary use.
Restricted to trained professionals and controlled laboratory settings.
Institutional approval and jurisdiction-specific compliance may be required.

Storage and handling

Keep sealed and protected from heat and light. Follow the vial label, analytical documentation, and the approved protocol for temperature, reconstitution, stability, and disposal requirements.